Bright Minds Bio - An Overview
Bright Minds Biosciences is a biotechnology company that is focusing on creating the next generation psychedelic drugs to help in the treatment of mental health conditions. The company’s primary focus is on creating products for the treatment of cluster headaches and depression – common problems faced by people across the world. The company has a subsidiary Psilocybin Labs that is carrying out research and development activities on psychoactive mushrooms and their effects on humans.
The Company focus
Bright Minds Bio has an experienced management team comprising professionals with expertise in science, chemistry, pharmaceutical R&D, drug design, and management. The company team has reputed scientists who have worked for more than 25 years in drug development. The team has a special experience in working with psychedelic compounds, their receptor sites, and the integration in the brain.
The company’s focus is on understanding the effect that receptors have on the body. With this foundational research, the company would strive to create new molecules that can provide more effective treatment for mental health conditions with lesser of the side effects that drugs have at present.
Areas of Therapeutic Application
Bright Minds Bio is using its strong scientific expertise to create next generation therapeutic drugs. Some of the key areas that the company is focusing on are:
1) Neuropsychiatry
The company is carrying out research on Psilocybin, which is the key psychoactive ingredient in magic mushrooms. The team believes that these compounds can play a key role in the treatment of major depressive disorder. The drugs that the company is planning to develop are focused on targeting the 5-HT2C receptors. The objective is to treat this condition without the patient having to face side effects like weight gain and increased addiction. The agonists the company is working on is expected to be helpful in treating patients with Parkinson’s disease and dementia, without the side effects of sleep and increased blood pressure.
2) Pain
Psychedelic drugs can be helpful in treating severe pain. Opioids used to alleviate pain can have significant side effects. Serotonin agents can be helpful in pain control. The team at Bright Minds is working on treatment options for chronic pain sufferers without side effects like drowsiness and addiction.
3) Epilepsy
A major problem in the treatment of epilepsy is the fact that patients develop resistance to drugs used for treatment. Nearly 40% of patients become resistant to drugs. This brings forth the need to have new drugs to treat epilepsy by using 5-HT2C agonists. The focus is on creating effective drugs that can treat epilepsy and prevent side effects, and also protect the brain.
With its focus on developing new drugs, Bright Minds Bio has been collaborating with some of the brightest minds in the scientific community. Partnerships have been established with eminent organizations like the National Institutes of Health, Medical College of Wisconsin, etc. These partnerships and the sustained efforts of the company will definitely help them in making a mark in the world of mental health therapeutics.
Comments
Post a Comment